Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:817279.
doi: 10.1155/2013/817279. Epub 2013 Dec 19.

Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments

Loredana G Marcu  1
Affiliations

Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments

Loredana G Marcu. Biomed Res Int. 2013.

Abstract

Advanced head and neck cancers are difficult to manage despite the large treatment arsenal currently available. The multidisciplinary effort to increase disease-free survival and diminish normal tissue toxicity was rewarded with better locoregional control and sometimes fewer side effects. Nevertheless, locoregional recurrence is still one of the main reasons for treatment failure. Today, the standard of care in head and neck cancer management is represented by altered fractionation radiotherapy combined with platinum-based chemotherapy. Targeted therapies as well as chronotherapy were trialled with more or less success. The aim of the current work is to review the available techniques, which could contribute towards a higher therapeutic ratio in the treatment of advanced head and neck cancer patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Risk of leukaemia as a function of the cumulative dose of platinum agents (based on Travis 1999 data [20]).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA: A Cancer Journal for Clinicians. 2013;63(1):11–30. - PubMed
    1. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. Journal of Clinical Oncology. 2000;18(7):1458–1464. - PubMed
    1. Budach W, Hehr T, Budach V, Belka C, Dietz K. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006;6, article 28 - PMC - PubMed
    1. Lawrence TS, Blackstock AW, McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Seminars in Radiation Oncology. 2003;13(1):13–21. - PubMed
    1. Lippert B, editor. Cisplatin—Chemistry and Biochemistry of a leading Anticancer Drug. Zürich, Switzerland: John Wiley & Sons; 1999.

Publication types

MeSH terms

LinkOut - more resources